Results 51 to 60 of about 5,029 (162)
OncoImmunology, 2019 Staphylococcus aureus is implicated in disease progression in cutaneous T-cell lymphoma (CTCL). Here, we demonstrate that malignant T cell lines derived from CTCL patients as well as primary malignant CD4+ T cells from Sézary syndrome patients are ...
Edda Blümel +18 more
doaj +1 more source
Arquivos de Neuro-Psiquiatria, 1997 Chronic myelopathy associated with T-lymphotropic virus type I (HAM) has been described as an endemic disease in several areas of the world, meanwhile there are few papers describing the association between HAM and adult T cell leukemia-lymphoma.
Virgínia Freitas +4 more
doaj +1 more source
Acneiform type of mogamulizumab‐associated rash
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Inga Hansen‐Abeck +5 more
wiley +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 7, Page 822-831, July 2025.Zusammenfassung Hintergrund Primär kutane B‐Zell‐Lymphome (CBCL) sind chronische Erkrankungen mit häufigen Rezidiven. Die Zeit bis zur nächsten Therapie (Time to next treatment, TTNT) ist ein Endpunkt, der den klinischen Nutzen von Therapieoptionen einschließlich der Patientenperspektive widerspiegelt.
Rohat Cankaya +6 more
wiley +1 more source
Clinical, Cosmetic and Investigational Dermatology, 2021 Jinjing Zhang,1 Shiyu Ma,1 Jinxiang Yu,1 Song Zheng,2 Yuan Miao,3 Pingping Wang,1 Xiaojing Yan1 1Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, People’s Republic of China; 2Department of ...
Zhang J +6 more
doaj
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy
Онкогематология, 2018 Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by skin infiltration with malignant monoclonal T lymphocytes.
O. M. Demina +2 more
doaj +1 more source
Case Reports in Oncology, 2018 Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary
Taku Fujimura +7 more
doaj +1 more source
Erupção a fármaco com eosinofilia e sintomas sistémicos (síndrome DRESS).
Acta Médica Portuguesa, 2008 Adverse cutaneous reactions to drugs are frequent, affecting from 2% to 3% of all hospitalized patients. But only about 2% of these cutaneous reactions are severe and seldom are fatal.
Inês Lobo +4 more
doaj +1 more source
An overview of cutaneous T cell lymphomas [version 1; referees: 2 approved]
F1000Research, 2016 Cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-Hodgkin’s lymphomas that are characterized by a cutaneous infiltration of malignant monoclonal T lymphocytes. They typically afflict adults with a median age of 55 to 60 years,
Nooshin Bagherani, Bruce R. Smoller
doaj +1 more source
Cytogenetic studies and clinical implications in patients with Sézary syndrome [PDF]
, 1976 Jacqueline Whang‐Peng +3 more
openalex +1 more source